Tera's Bid for Pusula Finans: An Unpriced Deal Built on Paper Gains

On September 9, Tera Yatırım Menkul Değerler — a Turkish brokerage with a leasing arm — told the market it had started talks to buy the shares of Pusula Finans Holding and its group companies. The disclosure, filed on Borsa Istanbul's KAP platform, named the pieces in the proposed deal: the holding itself, its asset manager Pusula Portföy, its securities business Pusula Yatırım Menkul Değerler, and the savings-finance firm Katılımevim. There is no binding contract and, pointedly, no price.

That last detail is the whole problem for anyone who tracks the group's shares. A reported takeover with no figure attached is not yet a thesis; it is a headline about negotiations. What a value investor can do before a number exists is open the box Tera wants and ask what it is actually worth — because the most interesting thing in that box is a record "profit" that is largely not cash.

Why a broker wants a savings machine

The tidy part of the deal is the asset manager. Tera Portföy runs about ₺694 billion in assets, ranking sixth in Turkey; Pusula Portföy adds ₺185 billion and sits thirteenth. Combined, they reach roughly ₺880 billion, which would put the house in fifth place in the sector, above Ziraat Portföy and just behind Yapı Kredi Portföy. That is the kind of scale consolidation that turns a fee business into a larger fee business with fewer, cheaper back offices. Add a brokerage to distribute the funds, and the rationale writes itself.

The messy part is Katılımevim. Savings finance ("tasarruf finansman") is the interest-free home-and-car purchase model that grew large in Turkey's high-rate environment: members pay a fixed amount monthly into a pool, the company holds and invests that money, and it disburses vehicles or homes to members over a long horizon — some by lottery, some on a queue. The business collects cash today and owes property-and-cash tomorrow, so its balance sheet is dominated by what its own members have contributed.

The record profit that will not repeat

Katılımevim has been the story the group sells to equity markets. In the first half of 2026 it reported a net profit of roughly ₺22.9 billion, about eight times the ₺2.8 billion of the year-earlier half. That number — and the way the holding has been buying Katılımevim stock while the price moved up — is what makes the group look exciting.

The source of the profit matters more than the headline. Of ₺25.5 billion in other operating income, about ₺23.6 billion — roughly 92% — came from gains on the investment funds the company holds with the pooled savings. Those are mark-to-market gains, not realized cash: the balance sheet's deferred tax liability jumped from ₺19 million to ₺700 million, the signature of paper appreciation that has not been converted into spendable income.

And the regulator is squeezing exactly that source. The BDDK, which licenses savings-finance firms, is mandating that these companies shift their funds into lower-risk money-market instruments, with the rules effective October 1. Katılımevim holds on the order of ₺42 billion in funds; pushing that into safe, low-yield paper is a direct cut to the earnings line the company just posted. The eightfold profit, in other words, was not just a spike — it was a spike in a category the rules are now designed to shrink.

The gate before any price reaches shareholders

Completion is not a formality. The transfer needs approvals from the securities regulator (SPK), the banking regulator (BDDK), and the competition authority. Of those, BDDK scrutiny is the real hurdle: it supervises both the savings-finance arms and the participation bank the group has been building, so a change of control there is a regulated event, not a private one.

That is where the picture for a minority holder turns concrete. Turkish law requires that when a buyer takes control of a listed company, it must offer to buy out the other shareholders at a regulated price — the mandatory tender offer — within about two months of acquiring control. If Tera ends up controlling the publicly traded holding, that mechanism is what will finally put a number on the minority shares, and it will have to be a justified price, not a friendlier one.

That unresolved price is the decisive test, and it is also the reason there is no rating to be had yet. Buying the holding gives control of the asset manager, the brokerage, and the savings-finance franchise; the savings-finance piece carries the large member liabilities, and its reported earnings are inflated by gains the October rules will compress. Whether a bid looks cheap depends entirely on what the group is worth net of that liability book once the paper gains are discounted — and nobody has said what they will pay for it. Until a figure appears, this belongs on a watchlist with two things to verify at once: the offer price, and how much of Katılımevim's profit is real once the fund gains stop counting.